Government monopoly would reduce quality of prescription drug coverage: study
MONTREAL | The obsession with reducing public spending on prescription drugs, which takes the form of constantly falling price caps, bulk purchasing strategies and reimbursement restrictions, entails numerous unintended consequences, especially for the health of Canadians, according to a new study from the Montreal Economic Institute.